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The identity of niche signals necessary to maintain
embryonic nephron progenitors is unclear. Here we
provide evidence that Fgf20 and Fgf9, expressed in
the niche, and Fgf9, secreted from the adjacent
ureteric bud, are necessary and sufficient to maintain
progenitor stemness. Reduction in the level of these
redundant ligands in the mouse led to premature
progenitor differentiation within the niche. Loss of
FGF20 in humans, or of both ligands in mice, resulted
in kidney agenesis. Sufficiency was shown in vitro
where Fgf20 or Fgf9 (alone or together with Bmp7)
maintained isolated metanephric mesenchyme or
sortednephronprogenitors that remainedcompetent
to differentiate in response to Wnt signals after 5 or
2 days in culture, respectively. These findings identify
a long-sought-after critical componentof thenephron
stemcell nicheandholdpromise for long-termculture
and utilization of these progenitors in vitro.
INTRODUCTION
Different mammalian organs deploy different strategies to fulfill
their physiological roles in the adult. The gut and the skin rely
on stem cells sequestered in specialized niches to maintain
homeostasis and recover from injury (Fuchs, 2008; Li and
Clevers, 2010). In contrast, the adult kidney has no identifiable
stem cells (Little and Bertram, 2009), displays limited repair
capacity (Humphreys et al., 2008) and relies instead on a large
surplus of nephrons generated from an embryonic pool of
stem cells/progenitors during development. Genetic and envi-
ronmental factors affect the number of nephrons; low numbersDevelopmcorrelates with renal diseases and hypertension (Bertram et al.,
2011; Keller et al., 2003; Myrie et al., 2011). Improved insight
into the nephron progenitors and their environment may help
maintain such cells for therapeutic purposes. Therefore, there
is growing interest in understanding the mechanisms that regu-
late these cells during nephrogenesis.
Mammalian renal progenitors are established in the meta-
nephric mesenchyme (MM) following ureteric bud (UB) out-
growth. The MM condenses around UB tips and induces tip
branching (Costantini and Kopan, 2010); the distal aspect of the
branched duct is a niche for embryonic multipotent stem/
progenitor cells (Boyle et al., 2008; Kobayashi et al., 2008).
Nephron progenitors located lateral or proximal to the UB tips
form a pretubular aggregate (PTA) before undergoing mesen-
chymal to epithelial transition generating the renal vesicle (RV).
The RV cells grow at different rates to form an S-shaped body
(SSB). Nephron progenitors located distal to the UB form
a ‘‘cap’’ and express the transcription factors Six2 and Sall1,
which play a critical role in maintaining stemness. Six2-deficient
progenitors differentiate en masse prematurely in a Wnt9b-
dependent manner (Kobayashi et al., 2008; Self et al., 2006),
causing renal agenesis. The UB is thought to play a dual role. It
makes an important contribution to maintaining progenitors
capable of self-renewal and it provides Wnt9b that promotes
differentiation of cap metanephric mesenchyme (CMM) (Carroll
et al., 2005; Karner et al., 2011; Kobayashi et al., 2008; Park
et al., 2007). This stemcell/progenitor populationdisappearsafter
producing1.53106 (human) or 1.33104 (mouse) nephrons, likely
due to the disappearance of their niche (Hartman et al., 2007).
Whether niche signals maintain stemness or block differentia-
tion is unclear. Paradoxically, Wnt9b may constitute part of the
niche signal (Karner et al., 2011). However, a niche ‘‘stemness’’
signal, if one exists, is expected to specifically maintain self-
renewal while keeping the cells competent to respond to differ-
entiation signals by generating multiple lineages. Such a mole-
cule would have therapeutic potential if it could be used toental Cell 22, 1191–1207, June 12, 2012 ª2012 Elsevier Inc. 1191
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in an artificial niche.
FGF ligands are among the candidates for the niche signal
required to maintain stemness because inactivation of FGF
receptors (Fgfrs) in the CMM results in arrested kidney develop-
ment (Poladia et al., 2006; Sims-Lucas et al., 2011). Supporting
the notion that FGF signals are essential for maintenance of
the nephron progenitor population is the observation that sup-
plementing isolated MM cells with FGF2 (which is not present
in the CMM) and Bmp7 (which is) can maintain their short-term
competence in culture (Dudley et al., 1999). Generally, FGF
ligands expressed in mesenchymal tissues signal to epithelial
splice forms of FGFRs (‘‘b’’ splice forms), whereas ligands ex-
pressed in epithelial cells signal to mesenchymal splice forms
of FGFRs (‘‘c’’ splice forms; Zhang et al., 2006). Based on this,
the ligand may be provided to the CMM by an epithelial source,
(i.e., the UB). CMM cells express Fgf7 and Fgf10, which signal to
epithelial Fgfr2b in the UB. Targeted deletion of Fgf7 leads to a
reduction in ureteric branch number due to decreased signaling
through Fgfr2b and secondarily, to fewer nephrons (Bates, 2011;
Qiao et al., 1999). Fgf8, expressed in the nascent RV, is required
for progression from PTA to RV and for its proliferation (Gries-
hammer et al., 2005; Perantoni et al., 2005). Loss of Fgf8 results
in apoptosis of MM due to loss of a PTA-derived signal, most
likely Wnt4 (Grieshammer et al., 2005; Perantoni et al., 2005).
Although these studies point to an important role for FGF sig-
naling in maintaining the MM, the ligands that signal to mesen-
chymal Fgfrs in vivo have not been identified.
Here, we investigate the role of the Fgf9 subfamily in renal
development and discovered that Fgf9 acts redundantly with
Fgf20 to promote the proliferation, survival and stemness of
CMM progenitors in vivo. Moreover, we identified a human
missense mutation in FGF20 that results in bilateral renal agen-
esis. We show that either Fgf9 or Fgf20 is sufficient to main-
tain differentiation-competent, Six2+ nephron progenitors
in vitro for 5 days, whereas cells grown in Fgf8 or Fgf10 lose com-
petence by 48 hr. Sorted Six2+ cells retained competence to
form epithelia for at least 48 hr in culture when grown in
serum-free media containing Fgf9/BMP7. These studies identify
Fgf20 (and Fgf9) as integral parts of the CMM niche where they
act to maintain a self-renewing progenitor population competent
to respond to an inductive cue. This work lays the foundation for
creating an artificial renal stem cell niche.
RESULTS
Fgf20 and Fgf9 Act Redundantly and Are Essential for
Kidney Development
The Fgf20 gene was targeted by insertion of a b-Galactosidase
(bGal) cDNA into exon 1 (Huh et al., 2012). Fgf20bGal/bGal mice
are viable, fertile, and have a normal lifespan. They also display
several phenotypes, including sensorineural hearing loss due
to defects in the development of the organ of Corti (Huh et al.,
2012). Examination of E18.5 kidneys from Fgf20bGal/bGal embryos
revealed a reduction in kidney size (15%) relative to control
kidneys (n = 8, p < 0.03). Counts confirmed that fewer Glomeruli
formed in Fgf20bGal/bGal and Fgf20+/bGal kidneys relative to wild-
type (15,684 ± 3,035 versus 22,350 ± 2,733; p < 0.001; 19,392 ±
3,070 versus 22,350 ± 2,733, respectively; p < 0.003; Figure 1I).1192 Developmental Cell 22, 1191–1207, June 12, 2012 ª2012 ElsevThe adrenal glands, gonads, and Wolffian duct of Fgf20bGal/bGal
were indistinguishable from wild-type, as was the gross
histology of Fgf20bGal/bGal kidneys (Figure 1B; see also Figures
2 and 3). The intermediate steps in nephron development (forma-
tion of the RV, SSB and early glomeruli) were comparable to
control (white line, Figures 1F–1G0, arrow SSB and arrowhead
glomeruli). Thus, the overall smaller size was consistent with
a smaller progenitor pool that differentiated normally.
Related FGFs have similar biochemical properties and devel-
opmental functions (Itoh and Ornitz, 2011; Zhang et al., 2006).
We thus tested if the other members of the same subfamily
(Fgf9, Fgf16) had redundant functions with Fgf20 in kidney
development by generating compound Fgf9 and Fgf20 mutant
animals. Fgf20 compound heterozygous (Fgf9+/–;Fgf20+/bGal
andFgf9/;Fgf20+/ßGal) embryosdidnotexhibit anygrossabnor-
malities (n = 10 and 6, respectively; Figure 1C) Fgf9-deficient
embryos display aberrant development of the male reproductive
tract with no kidney abnormalities (Colvin et al., 2001a; Kim and
Capel, 2006), anddie after birth due to lungmalformations (Colvin
et al., 2001b); therefore, all subsequent analyseswere conducted
at E18.5 unless stated otherwise. In contrast, all Fgf9+/–;
Fgf20bGal/bGal embryos had hypoplastic kidneys (n = 8). The
defects ranged from mild (15% reduction in 8/15 kidneys, p =
0.005; Figure 1D0) to severe (60% reduction in 6/15 kidneys, p <
0.001; Figure 1D00). One embryodisplayedbilateral renal agenesis
(similar to Figure 1E). No defects were detected in the adrenal
glands, gonads, Mullerian ducts, ductus deferens, or bladder.
Significantly, histological analysis revealed that in Fgf9+/–;
Fgf20bGal/bGal kidneys, large areas of the nephrogenic zone
were missing, replaced by more mature tubular structures
(Figures1Hand1H0, arrowheads).Kidneyagenesiswasobserved
in all Fgf9/; Fgf20bGal/bGal embryos examined (n = 6, Figure 1E,
yellow arrowhead). In this genetic background, the adrenal
glands were reduced in size (Figure 1E, white arrowhead).
These findings indicate that Fgf9 and Fgf20 function redun-
dantly during kidney development to maintain the nephrogenic
zone. Because one allele of Fgf20 in Fgf9 null embryos is enough
to support normal kidney development, whereas Fgf9+/–;
Fgf20bGal/bGal mice display a severe phenotype, Fgf20 seems
to have a more dominant role than Fgf9 in the kidney.
Reduction in Fgf9 and Fgf20 Levels Lead to Loss of
Nephron Progenitors and Premature Differentiation
To better characterize Fgf9 and Fgf20 deficient kidneys, we
examined the expression of several molecular markers of
nephron progenitors and their differentiated descendents in
control, Fgf20bGal/bGal and Fgf9+/–; Fgf20bGal/bGal dysplastic
kidneys. The UB (Cytokeratin 8, Ck8) branched and formed a
collecting duct in both control and mutant mice (Figures
2A–2E). Wilms tumor 1 (WT1) was highly expressed in the podo-
cytes, and Lotus tetragonolobus lectin (LTL)-positive proximal
convoluted tubules (PT) were readily detected. This and the
fact that some Fgf9+/–; Fgf20bGal/bGal mice survive to adulthood,
confirmed the presence of mature, functional nephrons, albeit in
reduced numbers within smaller, dysplastic kidneys (Figures
2A–2E). Loss of Six2-positive CMM occurred in patches, consis-
tent with an overall reduction in nephron progenitors (see below).
As noted before, large areas in the nephrogenic zone of E18.5
Fgf9+/–; Fgf20bGal/bGal kidneys were replaced by matureier Inc.
Figure 1. Fgf20 and Fgf9 Are Required for Kidney Development
(A–C) Normal urogenital system formed in control (A), Fgf20bGal/bGal (B), and Fgf9+/–; Fgf20+/bGal (C) embryos. Note slightly smaller kidneys in (B) but
not in (C).
(D–D00) Fgf9+/–; Fgf20bGal/bGal embryos developed mild (D0) to severe (D00) reduction in kidney size.
(E) When both alleles were deleted the kidneys were absent (yellow arrowhead) and adrenal glands were smaller (white arrowhead).
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FGF9/20 Maintain Stemness of Nephron Progenitorsstructures (Figures 2C and 2E, white arrows). Six2-expressing
nephron progenitors also express Pax2 (paired-box homeotic
transcription factor 2) and low levels of WT1 protein. These
progenitors form one or two cell layers distal to each UB tip in
both control (Fgf20+/bGal) and in most tips in Fgf20bGal/bGal
kidneys (Figures 2A, 2A0, and 2D0, yellow arrowheads) at E18.5.
In contrast, in Fgf9+/–; Fgf20bGal/bGal kidneys, three phenotypic
categories can be discerned: normal CMM (Figure 2, yellow
arrowheads), reduced progenitor numbers (Figures 2B0, 2C0,
and 2E0, white arrowheads, also seen near a few tips in
Fgf20bGal/bGal kidneys), or loss of progenitors leading to mature
structures distal to UB tips (white arrows in Figures 2C, 2C0,
and 2E0).
To determine if these defects were intrinsic to the progenitors,
we cultured E11.5 metanephroi of various genotypes for 2 days
and stained for Ck8 and Six2. Fgf20bGal/bGal metanephroi were
smaller than controls. To evaluate progenitor pool size, we
counted the number of tips surrounded by Six2+ cells in each
genotype (see Experimental Procedures for detail). Whereas
UB tips in control animals were surrounded with Six2+ cells,
33.7% of Fgf20bGal/bGal UB tips were surrounded by fewer
Six2+ cells (Figure 3C, yellow arrows) and 12.4% lacked Six2+
cells altogether (Figure 3C, blue arrows; quantification in Fig-
ure 3M and Table S1). Fgf9+/–; Fgf20bGal/bGal metanephroi dis-
played a more severe phenotype (41% had fewer and 29.8%
had no Six2+ cells; Figures 3D–3F and 3M). Staining for the
RV-SSB differentiation marker Jagged1 (Jag1) (Cheng et al.,
2003, 2007) detected numerous Jag1+ epithelial differentiating
distal to the UB tip, where Six2-expressing mesenchyme should
reside (Figures 3H–3L, white arrows). Consistent with premature
differentiation in the niche, Wnt4 was ectopically expressed in
cells surrounding UB tips in Fgf9+/–; Fgf20bGal/bGal metanephroi
(Figure 3K, white arrows). These observations are consistent
with the hypothesis that Fgf9 and Fgf20 act to prevent premature
differentiation of nephron progenitors, reminiscent of Six2-
deficient mice (Self et al., 2006) or mice expressing constitutively
active Notch in the CMM (Boyle et al., 2011; Cheng et al., 2007;
Fujimura et al., 2010).
Fgf20 Is Expressed Exclusively in Nephron Progenitors,
Whereas Fgf9 Signals Mostly from the UB
To determine the temporal and spatial expression patterns
of Fgf20, we analyzed FGF20-bGal activity during kidney devel-
opment. Whole-mount X-gal staining at E10.5–E12.5 clearly
showed activity in mesonephric and metanephric kidneys
(Figures 4A–4C, black and red arrowheads, respectively). At
E14.5, bGal activity was present in the MM surrounding the UB
(Figure 4D). To identify the specific cell population that ex-
pressed Fgf20, we stained sections of Fgf20bGal/bGal kidneys
with antibodies against Ck8, neural cell adhesion molecule
(NCAM, marking mesenchymal cells and their epithelial deriva-
tives) and bGal. At E16.5, bGal colocalized with Six2 in CMM(F–G0) H&E staining of kidneys from control (F) and Fgf20bGal/bGal (G) mice shows
zone thickness (cyan line) is indistinguishable between Fgf20bGal/bGal and control k
in nephron development (SSB, arrow; early glomeruli, arrowhead in G0).
(H) Kidney section of Fgf9+/–; Fgf20bGal/bGal embryo showed regions where the n
(H0 and I) High power image of boxed area in (H). Glomeruli were counted from
(in thousands with SD) is shown in (I). *p = 8.1775 3 108. B, bladder; G, gonad;
1194 Developmental Cell 22, 1191–1207, June 12, 2012 ª2012 Elsevcells (Figures 4E and 4F, white arrows). bGal activity persisted
in the nascent RV due to expression or perdurance (Figure 4E,
yellow arrowhead) but not in the stroma or the UB (Figures 4E
and 4F). We therefore conclude that in the metanephric kidney,
Fgf20 is expressed exclusively in nephron progenitors. This
pattern agrees with the mRNA expression data collected by
GUDMAP (Little et al., 2007) and presented in (Brown et al.,
2011). The same resource describes Fgf9 expression as most
abundant in the UB, with MM expression detected P0-P2 (see
Figure S1 available online). mRNA for both ligands disappears
as the remaining progenitors differentiate en masse.
Conditional inactivation of Fgfrs in the CMM caused renal
agenesis (Poladia et al., 2006), mimicked by Fgf9/20 compound
mutants (Figure 1). Because Fgf9 is expressed in the duct (Bar-
asch et al., 1997; Brown et al., 2011; McMahon et al., 2008), we
hypothesized that Fgf9 is a paracrine signal from the duct to the
CMM and FGF20 acts in an autocrine manner on the CMM itself.
To test this, we inactivated a conditional allele of Fgf9 (Fgf9f/f; Lin
et al., 2006) specifically in the UB, with the HoxB7-Cre BAC
transgene (Yu et al., 2002). Removal of both Fgf9 alleles from
the UB in Fgf20+/bGal embryos permitted normal development
(Figures 4G, 4H, 4K, and 4K0). Conversely, when a single allele
of Fgf9 was removed from the UB of Fgf20bGal/bGal embryos
(HoxB7-Cre+/tg; Fgf9+/f; Fgf20bGal/bGal), dysplastic, smaller
kidneys formed (25%–75%; n = 10; Figure 4I). Examination of
these kidneys (Figures 4L and 4L0) revealed depletion of nephron
progenitors similar to that seen with global loss of an Fgf9 in this
background (Figure 2). Fgf20 null embryos lacking both Fgf9
alleles in the UB (HoxB7-cre+/tg; Fgf9f/f; Fgf20bGal/bGal) displayed
rudimentary kidneys (n = 6) or renal agenesis (n = 4) (Figure 4J),
a phenotype slightly milder than the Fgf9/Fgf20 compound null.
To ask if Fgf9 was expressed in the MM, we deleted Fgf9 from
the mesenchyme using the Pax3-Cre allele (Cheng et al., 2007;
Li et al., 2000). Some Pax3-Cre+/tg; Fgf9f/f; Fgf20bGal/bGal mice
have rudimentary kidneys (Figure S1), consistent with Fgf9 also
being expressed in the mesenchyme. These data support
a model in which Fgf9 secreted from the UB complements the
activity of Fgf20 and Fgf9 produced in the CMM.
FGF20Loss IsAssociatedwithRenalAgenesis inHumans
Independently, we used a combined approach of homozygosity
mapping and exome sequencing to analyze a consanguineous
family with several fetuses presenting with isolated bilateral renal
agenesis. Autopsy revealed the Potter sequence and bilateral
reno-ureteral agenesis (Figure 5A) in one fetus. Other organs
were normal. DNA analysis from this fetus identified homozy-
gous variants in four genes expressed during early kidney devel-
opment and located in homozygous chromosomal regions. One
of these mutations was a single base-pair deletion in exon 2 of
FGF20, resulting in a frameshift starting at amino acid 113
and terminating in a stop codon at position 121, before the
third heparin-binding domain of the protein (Figures 5B–5D,bilateral reduction in kidney size of mutant compared to control. Nephrogenic
idneys. High power image of boxed area in (G) shows normal intermediate steps
ephrogenic zone was depleted (arrowheads).
four control, five Fgf20+/bGal, and five Fgf20bGal/bGal kidneys. Average count
K, kidney. Scale bar represents 500 mm.
ier Inc.
Figure 2. Loss of Nephron Progenitors in Fgf9/20 Mutants
Sections of E18.5 kidneys stained with Ck8 (purple, UB), WT1 (red; low, CMM; high, podocytes), LTL (blue, proximal tubules), Six2 (green, progenitors) or Pax2
(UB, nephron progenitors and nephron epithelia).
(A and D) The nephrogenic zone in controls (green) is located distal to the UB and to glomeruli (red) attached to proximal tubules (blue). (A0 and D0) High power
image of control nephrogenic zone showed progenitors (yellow arrowheads) packed in two compact cell layers distal UB tips.
(B and B0) The nephrogenic zone near some tips in Fgf20bGal/bGal kidneys contains fewer Six2+ cells relative to controls but is otherwise indistinguishable (high
power view in B0).
(C–E0) Fgf9+/–; Fgf20bGal/bGal kidneys contained many cortical areas where the nephrogenic zone was replaced by mature structures (white arrows) (C–E). High
power image of nephrogenic zone from Fgf9+/–; Fgf20bGal/bGal kidneys (C0–E0). The cortex contained some UB tips surrounded by two cell layers of nephron
progenitors (yellow arrowheads), other tips with fewer Six2+ cells (white arrowheads), and some lacking a nephrogenic zone altogether contained mature
nephrons instead (white arrows). Scale bars represent 100 mm.
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Figure 3. Reduced Fgf9/20 Levels Allow Premature Differentiation of Nephron Progenitors in the Niche
(A–F) E11.5 metanephroi analyzed after 48 hr in organ culture. Fgf20bGal/bGalmetanephroi (B and C) were smaller than controls (A). Some UB tips in Fgf20bGal/bGal
metanephroi (B-C) or Fgf9+/–; Fgf20bGal/bGalmetanephroi (D–F) are surrounded by fewer Six2+ cells (yellow arrow), whereas others lack Six2 expressing cells (blue
arrows).
(G–K) Jag1 (epithelial RVs and SSBs), Ck8 (UB), and Six2 (nephron progenitors) demonstrate premature differentiation in the niche in metanephroi distal to some
UB tips (white arrows).
(L) In situ hybridization ofWnt4 (blue) and antibody staining to Ck8 (brown) shows ectopicWnt4 expression distal to UB tips in Fgf9+/–; Fgf20bGal/bGalmetanephroi
(white arrows).
(M) Quantification of tip subtypes (marked with yellow or blue arrows) in metanephroi of various genotypes (Table S1). Normal progenitor numbers in dark green
reduced progenitors numbers in light green; no progenitors in pink. Scale bars represent 100 mm.
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FGF9/20 Maintain Stemness of Nephron Progenitorsmutation [c.337delG]). Sanger sequencing analysis confirmed
homozygosity for the FGF20 c.337delG mutation in this fetus.
Moreover, we showed that the mutation was homozygous in1196 Developmental Cell 22, 1191–1207, June 12, 2012 ª2012 Elsevtwo other affected fetuses in the family and heterozygous in
the parents with available DNA (Figure 5B). This mutation was
absent in a healthy sibling (Figure 5B), from dbSNP and theier Inc.
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exome sequence data. Moreover, the three other homozygous
variants identified in this fetus did not segregate with the kidney
defect in this family. Combined with the mouse mutants de-
scribed above, these data point to FGF20 as an essential pro-
tein during mammalian metanephric kidney development whose
loss is sufficient to cause bilateral renal agenesis in humans.
In the Absence of Fgf9 and Fgf20, Nephron Progenitors
Form but Are Not Maintained
Renal epithelia fail to form in humans lacking FGF20 or in mice
lackingFgf9andFgf20.Wenext asked if kidneyagenesis reflected
failure to establish the CMM (Costantini and Kopan, 2010) or
failure to maintain the progenitors. Because the CMM induces
UB outgrowth, we asked if UB induction was initiated properly
in mutants by whole-mount Ck8 staining. By E11.5, control
embryos had an elongated, T-shaped UB (Figure 6A). Fgf9/;
Fgf20bGal/bGal embryos initiated UB outgrowth, but in contrast,
we only observed a branched UB in two out of seven embryos
(Figure 6B). To examine the MM, transverse sections of E11.5
embryos were prepared. In all embryos, the elongating UB con-
tacted the Pax2-positve MM (Figures 6C–6H). Control MM cells
condensed around the UB in wild-type embryos (Figure 6C),
whereas the Fgf9/; Fgf20bGal/bGal MM was significantly smaller
and most cells failed to coalesce around the UB (Figure 6D).
TUNEL staining detected many apoptotic cells within the MM of
Fgf9/; Fgf20bGal/bGal embryos at E11.5 (Figures 6E and 6F). By
E12.5, only a few Pax2+, Ck8– cells remained in themesenchyme
(Figures 6G and 6H). This analysis suggested that, in the
absence of Fgf9 and Fgf20, UB outgrowth was initiated, but the
rudimentary MM failed to migrate toward the UB and, in addition
to prematurely differentiating (Figures 3K and 3L), underwent
high rates of apoptosis reminiscent of isolated MM cells in vitro
and in Fgfr-deficient MM in vivo (Poladia et al., 2006). Analysis of
Pax2 and Gdnf expression in the MM revealed that their expres-
sion correlated with the dose of Fgf9/20 as early as E10.5–
E11.5. In contrast, Pax2 (Figure 6) and cRet expression (data not
shown) in the UB was unchanged. It cannot be ruled out that
Fgf9 has a function in maintaining Etv4 and Etv5 in the UB epithe-
lium (data not shown). The consequence of reduction inGDNF/ret
signaling was progressive failure in branching morphogenesis
(data not shown), which could be reversed in vitro by the addition
of GDNF to metanephroi with limited branching (Figure S2).
Fgf9 Maintains Isolated Progenitors Competent to
Respond to Inductive Signals In Vitro
The data presented thus far shows that Fgf20 and Fgf9 together
are required for maintenance and survival of nephron progeni-
tors in mice, and infer a similar activity for FGF20 in humans.
Moreover, our allelic series indicates that stemness and survival
were sensitive to the dose of Fgf9/20 (predicting reduced
nephron numbers in humans heterozygous for FGF20). To test
if these ligands were sufficient to mimic the niche, we examined
the ability of recombinant FGF9 to preserve the stemness of iso-
lated nephron progenitors in vitro. MM was isolated from E11.5
kidneys and explants were grown in serum free media supple-
mented with heparin (an important cofactor for FGF signaling;
Yayon et al., 1991), or heparin plus FGF9. In this and subsequent
experiments, the absence of UB was confirmed by Ck8 staining.DevelopmTo assess survival, we used TUNEL staining; to identify mitotic
cells, we used anti phospho-histone H3 (pHH3) antibody. As
reported, the majority of isolated MM cells were TUNEL-positive
after 4 days in media (Figure 7A). When heparin was added,
a greater number of cells survived and some mitotic cells were
seen (Figure 7B). The addition of FGF9 and heparin improved
both survival and proliferation (Figure 7C). Anti-Cited1, Wt1
(not shown), and Six2 antibody staining 48 hr after MM isola-
tion confirmed that these markers were maintained in ex-
plants cultured in heparin/FGF9-containing media (Figures 7E
and 7E0), but not with heparin alone. Some Six2-expressing cells
were mitotic (Six2+; pHH3+; Figures 7F–7I). These data demon-
strate that the addition of FGF9was sufficient to promote survival
and support proliferation of some nephron progenitors in vitro.
Next we asked whether nephron progenitors grown in the
presence of FGF9 retained their competence to respond to
inductive signals. To avoid introduction of renal tissue, we
used freshly dissected dorsal spinal cord segments (dSC; Saxe´n
and Lehtonen, 1987; Saxe´n and Sariola, 1987) as a source ofWnt
(Herzlinger et al., 1994; Kispert et al., 1998). After 48 hr in
heparin/FGF9 media, dSC was added and the cells were main-
tained for an additional 2–4 days in serum-free media. All freshly
isolated control MM grown in contact with the dSC underwent
MET (data not shown). After 2 days in vitro, only FGF9-
supplemented MM differentiated into epithelia expressing either
early distal (Cdh1) or proximal (Jag1) markers and retaining a few
Six2+ progenitors (Figures 7J and 7K). The fact that these tubular
structures contained at least two differentiated cell types (distal
and proximal epithelial cells) strongly suggests that progenitor
multipotency was retained.
It is clear that Fgf20 plays a more dominant role than Fgf9
in vivo and that any other Fgfs present in the cortex during devel-
opment (Fgf2, Fgf8, and Fgf10) cannot rescue the niche in the
absence of Fgf9 and Fgf20. Fgf9 and Fgf20 share biochemical
properties that may be unique among Fgf ligands expressed in
the vicinity of the niche. To test this possibility, we cultured iso-
lated E11.5 MM for 48 hr in heparin supplemented media and
added FGF9, FGF20, FGF8, or FGF10. First, we established
the activity of our recombinant proteins on FGFR2b and FGFR2c
splice variants stably expressed in Baf3 cells (Ornitz et al., 1996).
Although FGF8, FGF9, and FGF20 all activated the mesen-
chymal FGFR2c splice form (Figure S3), only FGF9 (7/9 explants)
or FGF20 (9/10 explants) could maintain Six2+ cells. Very few
Six2-expressing cells (10 cells/explants) were seen in the pres-
ence of FGF8 (7/7 explants); none were detected in eight
explants exposed to FGF10 (Figure S3). In summary, these
data demonstrated that members of the Fgf9/20 subfamily are
necessary and sufficient to promote survival, competence, and
multipotency of MM cells in vitro.
Bmp7 Synergizes with Fgf9 to Promote Survival
and Competence of Nephron Progenitors In Vitro
FGF2 and BMP7 synergized to improve maintenance of nephron
progenitors in vitro (Dudley et al., 1999). To test if BMP7 can
enhance the effect of the endogenous niche ligand, we cultured
isolated MM in media supplemented with BMP7 and FGF9.
Whereas isolated MM supplemented with BMP7 alone lost their
Six2+ population (Figure 8A), BMP7/FGF9 seemed to increase
the overall number of Six2+ cells and induced nephronental Cell 22, 1191–1207, June 12, 2012 ª2012 Elsevier Inc. 1197
Figure 4. Fgf20 Expressed in Nephron Progenitors and Fgf9 Secreted from the UB Collaborate to Maintain the Niche
(A–C)Whole-mount x-gal staining at E10.5-12.5 Fgf20+/bGal embryos detects bGal activity (blue) in themesonephros (black arrowheads) andmetanephric kidneys
(red arrowheads).
(D) X-gal staining identified activity in the MM of E14.5 Fgf20+/bGal kidneys (black dashed line-UB).
(E) Ck8, NCAM (epithelia), and bGal (Fgf20 expression domain) staining of E16.5 Fgf20bGal/bGal kidneys. bGal protein was detected in the CMM (white arrows). The
weak signal in the nascent RV (yellow arrowheads) may be due to expression or perdurance.
(F) Six2 identified nephron progenitors that contained bGal protein.
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FGF9/20 Maintain Stemness of Nephron Progenitorsprogenitors to sort away from Six2– cells and aggregate, con-
founding efforts to count them (Figures 8B and 8B0). In the pres-
ence of dSC, numerous epithelial structures containing distal
(Cdh1+) and proximal (Jag1+) cells formed, each surrounded
by a tight cluster of Six2+ cells (Figures 8C and 8D). To assess
for self-renewal of nephron progenitors in media supplemented
with BMP7 and FGF9, EdU (5-ethynyl-20-deoxyuridine) was
added to freshly isolated MM for 4–7 hr; MM cells were then
washed and re-fed with BMP7/FGF9 media every 12 hr. After
2 days, many Six2+ cells that remained EdUbright (Figures 8E–
8H, yellow arrows) were detected, suggesting that they only
divided once. A few Six2+, EdUDimm cells (progenitors that
divided once after labeling or labeled late in S phase) were in
mitosis after 48 hr (stained by pHH3; Figures 8E–8H, turquoise
arrow). Because mammalian S, G2, and M phases are relatively
fixed in length, such double labeling indicates that some nephron
progenitors were able to divide twice (one immediately after
culture, the other 2 days later) in thepresenceofBMP7andFGF9.
To ask if Six2+ cells could be maintained for as long as they
live in vivo (from E11.5 to P2, or 8 to 10 days), we cultured iso-
lated MM with FGF9 and BMP7 for 8 days in culture. Notably,
although some Six2 expressing cells were in mitosis (Six2+;
pHH3+; Figures S4A–S4C, yellow arrows), the proportion of
Six2+ cells declined after 5 days under these conditions (Figures
8I and 8I0); by day 8, only a few Six2+ cells were detectable (data
not shown). Staining for differentiation markers after 5 days
confirmed that no Cdh1 or Cdh6 expressing epithelia formed in
the absence of inducers (data not shown). Importantly, after
5 days in heparin/FGF9/BMP7 media in vitro, Six2+ nephron
progenitors formed epithelial tubules when cocultured with
dSC for an additional 4 days in basal media (9/9, three individual
MM each in three repeats). These epithelia expressed either
proximal (Cdh6) or distal (Cdh1) markers (Figure 8J).
Finally, to determine if FGF9 acted directly on Six2+ cells or
indirectly through FoxD1+ stromal cells, we sorted GFP+ cells
by FACS from Six2-GFP::CREtg/+ kidneys. Small colonies of
Six2+ cells, maintained for 48 hr in serum free media supple-
mented with FGF9, remained competent to differentiate (Fig-
ure 7L). Culturing these cells with FGF9+BMP7 for 48 hr resulted
in robust expansion of many more Six2+ colonies (Figures 8K
and 8K0) that maintained competence to respond to differentia-
tion signals and produced epithelia expressing either proximal
(Cdh6) or distal (Cdh1) markers after coculture with dSC (Fig-
ure 8L). Mitotically active nephron progenitors (Six2+; pHH3+)
survived after 5 days (Figures S4E and S4F, yellow arrows).
Although when cultured with dSC they could form a few Cdh1-
or Cdh6-positive cells, tubular epithelia no longer formed (data
not shown). These data demonstrate that Fgf9/Bmp7 act directly
on progenitors, promoting their survival while maintaining their
competence to respond to inductive signals for at least 2 days.(G–J) Urogenital system in mice lacking Fgf9 in their UB. Control (HoxB7-Cre+/
(G and H). In contrast, HoxB7-Cre+/tg;Fgf9+/f;Fgf20bGal/bGal kidneys are smaller (I).
Fgf20bGal/bGal embryos (J).
(K and L0) Ck8 (magenta), WT1 (red), LTL (blue), and Six2 (green) staining of Hox
(L) kidneys. Note large cortical areas where the nephrogenic zone was replaced b
control HoxB7-Cretg; Fgf9f/f; Fgf20+/bGal kidney (K0, yellow arrowheads) or HoxB7
structures (podocytes: red; proximal tubules: blue) located instead at edge of kidn
(E and F), 500 mm (G–J), and 100 mm (K–L0). See also Figure S1.
DevelopmDISCUSSION
Here we present data demonstrating that members of the Fgf9
ligand family are bona fide secreted niche signals in the devel-
oping mammalian kidney. FGF20 acts alone in humans but is
redundant with Fgf9 in mouse. In the absence of Fgf9 and
Fgf20, UB outgrowth initiates, but because the MM undergoes
a high rate of apoptosis, or because Fgf9 signals are needed
to maintain Etv4 and Etv5, UB branching is halted and kidney
development fails. In human fetuses homozygous for a truncated
allele of FGF20, no kidneys form. In mice, a single allele of Fgf20
(Fgf9-/–; Fgf20+/bGal) is sufficient tomaintain normal kidney devel-
opment in vivo (however, not in isolated MM), whereas a single
allele of Fgf9 (Fgf9+/–; Fgf20bGal/bGal) is insufficient. The redun-
dancy between Fgf9 and Fgf20 produced highly informative
variable phenotypes ranging from near normal kidneys to renal
agenesis.When Fgf9 and Fgf20 are at limiting doses, the balance
between differentiation and self-renewal is disturbed, Six2 ex-
pression is reduced, and precocious CMM differentiation can
occur suggesting a role for FGF signaling in the maintenance
of nuclear factors necessary for stemness (Osafune et al.,
2006; Sakaki-Yumoto et al., 2006; Self et al., 2006). Conse-
quently, many Fgf9+/–; Fgf20bGal/bGal kidneys contain regions
where nephron progenitors were replaced by differentiating
epithelia, reminiscent of MM lacking Six2 (Kobayashi et al.,
2008; Self et al., 2006). Members of the Fgf9 subfamily are
unique in that they can signal to both b and c splice forms of
some FGFRs (Figure S3E; Ornitz et al., 1996; Zhang et al.,
2006). However, autocrine Fgf9 also regulates epithelial growth
and branching (del Moral et al., 2006; White et al., 2006; Yin
et al., 2008, 2011). Although genetic deletion confirmed that
mesenchymal Fgf9 makes a measurable contribution to the
niche, the bulk of Fgf9 signals are provided from the epithelia
(UB) tomesenchyme (MM). In contrast, Fgf20was expressed ex-
clusively in the CMM, signaling in an unusual autocrine fashion to
maintain the mesenchymal cells in which it is expressed. Inter-
estingly, in the developing organ of Corti, Fgf20 provides an
autocrine signal acting within the epithelium to regulate its differ-
entiation (Huh et al., 2012).
Independently, other investigators observed that Bmp7, ex-
pressed in nephron progenitors, UB and PTA during early kidney
development (Dudley et al., 1995), acts to promote survival and
proliferation of nephron progenitors (Blank et al., 2009; Dudley
et al., 1995, 1999; Dudley and Robertson, 1997; Godin et al.,
1998). In Bmp7 null mice, the first round of nephrogenesis is
induced, followed later by loss of nephron progenitors, resulting
in premature termination of kidney development (Dudley et al.,
1995). Moreover, Fgf2, which like Fgf9 is expressed in the UB,
can promote survival and maintain competent MM cells in vitro
(Barasch et al., 1997; Dudley et al., 1999; Perantoni et al.,tg;Fgf20+/bGal) and HoxB7-Cre+/tg;Fgf9f/f;Fgf20+/bGal kidneys appeared normal
Fully penetrant kidney agenesis (yellow arrowhead) seen in HoxB7-cre;Fgf9f/f;
B7-Cretg; Fgf9f/f; Fgf20+/bGal (control, K) or HoxB7-Cretg; Fgf9+/f; Fgf20bGal/bGal
y mature structures (white arrows, L). High power image of nephrogenic zone of
-Cretg; Fgf9+/f; Fgf20bGal/bGal kidney (L0). Note regions lacking Six2 with mature
ey (white arrows). B, bladder; G, gonad; K, kidney. Scale bars represent 50 mm
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Figure 5. Identification of a Homozygous Frameshift Mutation in FGF20 that Segregates with Bilateral Renal Agenesis
(A) Bilateral reno-ureteral agenesis in the 18-week fetus; (a) adrenal glands with flat oval shape due to kidney agenesis.
(B) Pedigree of the consanguineous family showing two first cousin couples and four fetuses presenting with anhydramnios/bilateral renal agenesis; segregation
of the FGF20 c.337delG mutation is indicated.
(C) Nucleotide sequence traces and deduced amino acid sequence within exon 2 shown for wild-type (top) and mutated (bottom) alleles. Deleted guanine at
position 337 of the coding sequence is marked with asterisk in the wild-type sequence. The frameshift introduced missense amino acids from position 113 to 120
(in bold) and created a stop codon at position 121 (numbering as in NCBI sequence AB030648).
(D) Wild-type and deduced FGF20 proteins: heparin-binding domains indicated by light gray boxes; position of mutation is marked with red asterisk; the
8 missense amino acids are in black.
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FGF9/20 Maintain Stemness of Nephron Progenitors1995). However, FGF2 is not necessary in the niche as Fgf2 null
mice do not display a kidney phenotype (Zhou et al., 1998).
FGF2, FGF8, and FGF10 could not rescue Fgf9/20 null embryos,
indicating that their function does not overlap with Fgf9/20
during kidney development. FGF7 and FGF10 signal to the UB
and can replace GDNF when the inhibitor Sprouty1 is removed1200 Developmental Cell 22, 1191–1207, June 12, 2012 ª2012 Elsev(Michos et al., 2010). Fgf8 is expressed in the RV and in renal
epithelia and is needed for their maintenance (Grieshammer
et al., 2005; Perantoni et al., 2005). In vitro analysis confirmed
that FGF8 and FGF10 cannot maintain isolated MM, perhaps
due to higher affinity of Fgf8 to the decoy receptor Fgfrl1, which
is expressed in CMM (Brown et al., 2011). Moreover, severalier Inc.
Figure 6. Fgf9/20-Deficient Kidneys Initiate UB Outgrowth But Branching Fails Due to High Rates of Apoptosis in the MM
E11.5 whole-mount Ck8 staining in controls (A) illustrated a branched UB (white arrowhead). In contrast, the UB in Fgf9/; Fgf20bGal/bGal E11.5 embryos (B)
elongated (arrow) but failed to branch (yellow arrowhead). Sections of E11.5 kidneys stained with Pax2 (UB andMM) showedMM condensing around the UB tips
(Ck8+) in controls (C) but not in Fgf9/; Fgf20bGal/bGal embryos (D). The mutant MM appeared diffuse and formed a smaller contact zone with the UB. MM in
control is Pax2-positive and TUNEL-negative (E); the dyingMMcells in Fgf9/; Fgf20bGal/bGal embryos are TUNEL-positive (white arrowheads in F). At E12.5, Ck8
and Pax2 outline a rudimentary MM remaining in Fgf9/; Fgf20bGal/bGal embryos (H) compared to controls (G) (yellow arrowheads in G–H). See also Figure S2.
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FGF9/20 Maintain Stemness of Nephron Progenitorsother ligands capable of activating the PI3K pathway can act as
well as Fgf9 in maintenance of the progenitors (Brown et al.,
2011), but our in vivo analysis demonstrates that none can
rescue the loss of Fgf20 and Fgf9.DevelopmIn contrast to Fgf8, either Fgf9 or Fgf20 are sufficient to
support a Six2+ cell population that remained competent to
respond to dSC by differentiating into different cell types.
FGF9 maintains sorted, purified progenitors for at least 5 days;ental Cell 22, 1191–1207, June 12, 2012 ª2012 Elsevier Inc. 1201
Figure 7. Fgf9 Promotes Survival and Maintains Competence of Nephron Progenitors In Vitro
Isolated E11.5 MM cultured in defined media (M) (A), in heparin-supplemented media (M+H) (B), or in heparin and Fgf9 media (M+H+Fgf9) (C and E–K). Explants
were fixed and stained as indicated. After 4 days in media, the majority of MM cells were TUNEL-positive (A). When supplemented with heparin, cell survival
improved, some entering mitosis (B). In the presence of Fgf9, survival and proliferation were further increased (C). Isolated E11.5 MM was grown in culture for
2 days with M+H (D) or M+H+Fgf9 (E-I). Six2+ cells were only detected when Fgf9 was present (E and E0 ). A few progenitors (left-pointing arrowheads) positive for
Six2 (F), pHH3 (G), and DAPI (H) underwent mitosis (merged image; I). Nephron progenitors maintained in the presence of Fgf9 for 2 days are competent to
respond to Wnt produced by dSC by forming epithelial aggregates expressing both distal (Cdh1+) and proximal (Jag1+) markers (J and J0, higher magnification;
see text for detail). Note undifferentiated, Six2+ cells in (K). Colonies of Six2+ cells isolated by FACS were maintained for 2 days in culture in M+H+Fgf9 (L). Scale
bars represent 100 mm. See also Figure S3.
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FGF9/20 Maintain Stemness of Nephron Progenitorsthis is only possible if Fgf9 acted directly on the progenitors and
rules out an indirect role via an essential, Fg9-dependent UB or
stromal factor. Although restoring the unique cohesion of CMM
cells in vitro also requires Bmp7, this cohesion is not needed
for retention of competence; Fgf9 alone was sufficient to main-
tain Six2+ progenitors that are competent to differentiate in
response to Wnt. Nonetheless, Bmp7 helps to organize cells
into a structure that resembles the CMM niche, perhaps maxi-
mizing the benefits of endogenous Fgf20. At present, it is unclear
if conditions that allow robust growth rates are compatible with
maintaining competence as highly proliferative Six2+ cells in
nephrospheres lost their competence to differentiate (Lusis
et al., 2010).
It is thought that Wnt9b signals maintain stemness where Six2
is present and drives differentiation where Six2 is absent (Carroll
et al., 2005; Karner et al., 2011; Kobayashi et al., 2008; Self et al.,
2006). Although it is clear that self-renewing nephron progenitors
receive a Wnt9b signal within the CMM (Karner et al., 2011), it is
also evident that in the absence of Wnt9b, nephron progenitors
survive; they do not undergo apoptosis, and they remain compe-
tent to respond to inductive signals as late as E13.5 (Karner et al.,
2011). These observations indicate that signals other thanWnt9b
maintain competent nephron progenitors inWnt9bmutant mice,
and that in the absence of Wnt9b, proliferation is attenuated and
differentiation is lost. Fgf9 and Fgf20 could provide this signal;
both are Wnt-responsive genes in some contexts (Chamorro
et al., 2005; Karner et al., 2011). The details of the relationships
between Wnts and FGFs within the MM remain to be elucidated.
In conclusion, these observations suggest that, at a minimum,
Fgf9/20 and Bmp7 organize the nephron progenitor niche and
highlight the essential role of FGF20 in human kidney develop-
ment. Regulating the balance between self-renewal and differen-
tiation is key in determining nephron number, and lower nephron
numbers are correlated with higher risk for hypertension, kidney
disease, and recovery from injury. Our data indicate that FGF
signaling likely regulates multiple important steps in the niche,
including survival, proliferation, and competence. The relative
contribution of each of these to maintenance of a proper niche
is unclear. Because nephron progenitors do not persist in the
adult, understanding the mechanisms that regulate this niche
is a key step in the development of new therapeutic cell-
replacement approaches. The identification of the endogenous
niche ligands (Fgf9 and Fgf20) and the demonstration that they
can maintain purified progenitors for 5 days in vitro opens the
possibility for long-term maintenance of self-renewing nephron
progenitors in culture. The importance of such a culture for
research is self-evident; the therapeutic potential of these cells
will have to be empirically determined in various injury models.EXPERIMENTAL PROCEDURES
Mice
All mice were maintained in the Washington University animal facility accord-
ing to animal care regulations; Animals Studies Committee of Washington
University approved the experimental protocols (protocol 20110027). Lines
used here are: Fgf20bGal (Huh et al., 2012), Fgf9 (Colvin et al., 2001a), Fgf9f
(Lin et al., 2006), HoxB7-Cre+/tg (Yu et al., 2002), and Six2-GFP::CREtg/+
(Park et al., 2007). Mice and embryos were genotyped using the universal
PCR genotyping protocol (Stratman et al., 2003). Primers sequences available
upon request.DevelopmOrgan Culture
Isolation and culture of metanephric kidneys were performed as described
(Barak and Boyle, 2011). To manually isolate the MM, E11.5 metanephric
kidneys were dissected in cold PBS. Kidneys were treated with 2.25%pancre-
atin and 0.75% trypsin in Ca-Mg free Tyrode’s solution (pH7.4) (P/T solution)
for 30 s, then washed with FBS. MM was dissected from the UB using 26G
needles and placed on transwell filters. Explants were cultured at 37C, 5%
CO2 in defined medium (Barak and Boyle, 2011) supplemented with the
following as indicated. Heparin (1 mg/ml; Sigma), 8.6 nM FGF9 (PeproTech),
50 ng/ml BMP7 (R&D Systems), and 100 ng/ml FGF2 (PeproTech for positive
control, data not shown). FBS was added as carrier in stock solutions (same
results were obtained with BSA as carrier). Media was changed daily and
activity of FGFs protein was tested by a Baf3 assay as described (Ornitz
et al., 1996). To examine competence to respond to inductive signal, dSC
was isolated from E11.5–E13.5 embryos. Two fresh dSC segments were
placed adjacent to each MM explant. Explants were then cultured for an addi-
tional 2–4 days in unsupplemented media. At least three explants per treat-
ment were prepared for each experiment. Experiments were repeated at least
three times on different days. Staining for Ck8was performed to confirm exclu-
sion of UB remnants from explants.
Six2+ Cell Sorting
Kidneys were dissected from E14.5–E17.5 embryos from wild-type females
mated with Six2-GFP::CREtg/+ males. Both GFP-positive and -negative
kidneys were collected, with negative kidneys serving as sorting controls. To
dissociate the cells into single cell suspension, kidneys were treated with
pancreatin/trypsin diluted in Tyrode’s solution (Ca+2, Mg+2 free) for 15 min
on ice (200 ml per four to eight kidneys), followed by pipetting until clumps
were not visible. To stop digestion, 1 ml of cold DMEM with 10% FBS was
added to the 200 ml of enzyme solution. Cell suspension was then filtered
through a 50 mm filter (CellTrics-Partec disposable filters 04-004-2327),
collected in 1.5 ml tubes, and centrifuged for 4 min at 800 rpm. Media was
aspirated and cells were resuspended in FACS buffer (3% FCS in PBS).
GFP+ cells were sorted using a MoFlo high-speed flow cytometer (Dako
Cytomation, Fort Collins, CO). Gating was implemented based on negative
control profiles to select for live GFP-positive cells. Sorted cells were collected
in 1.5 ml tubes (50,000–100,000 cells per tube) containing kidney media with
5% FBS and kept on ice before plating. Finally, cells were spun down for
4 min at 800 rpm and plated directly on transwell filters in organ culture dishes
with kidney media supplemented with heparin containing Fgf9 or Fgf9 and
Bmp7. Media was changed every 12 hr.
Immunohistochemistry
Immunohistochemistry was performed as detailed in the Supplemental
Experimental Procedures.
Statistical Analysis and Imaging
Two-tailed unpaired t tests were performed for statistical analysis. Resulting
p values are noted in text. For comparison of kidney sizes, perimeter was
measured and used for statistical analysis. Images were acquired with a Zeiss
Axioimage Z1 equipped with an ApoTome or with stereomicroscope Leica
MZ10F.
Quantification of Nephron Numbers
Kidneys were dissected from P5 pups of Fgf20 WT (+/+), Fgf20 +/bgal (+/),
and Fgf20 bgal/bgal (/) mice. To dissociate the tissue, kidneys were chop-
ped into 2 mm2 pieces and digested in 5 ml of 6 N HCL at 37C for 90 min.
Tissue was further dissociated by repeated pipetting. ddH2O (25 ml) was
added to each sample, and samples were kept at 4C. To count the number
of nephrons, 100 ml of well-mixed suspension was placed onto a 1 cm 3
1 cm area in a p100 culture dishmarkedwith gridlines. The number of glomeruli
were counted under an inverted microscope five times. Total number of
glomeruli was estimated as follows: total nephron number per pair of kidneys =
average number of glomeruli in 100 ml 3 300.
Patients and Whole Exome Sequencing
The fetus studied by exome sequencing (fetus 2 in Figure 5B) was an 18-week
gestation male terminated for recurrence of bilateral renal agenesis with anhy-
dramnios. The couple was consanguineous (first cousins) Caucasian; theental Cell 22, 1191–1207, June 12, 2012 ª2012 Elsevier Inc. 1203
Figure 8. Fgf9 Synergized with Bmp7 to Promote Self-Renewal of Competent Nephron Progenitors In Vitro
Isolated E11.5 MM was grown for 48 hr in media supplemented with Bmp7 (A) or heparin with Fgf9 and Bmp7 (M+H+Fgf9+Bmp7) (B–J). Six2+ cells were not
detected in explants grown with Bmp7 (A). In explants cultured in M+H+Fgf9+Bmp7, many Six2+ cells are detected (B and B0). Note that Six2+ cells sorted into
a tight cluster with a clear boundary separating them from Six2– cells (B). Adding dSC to cells pretreated by M+H+Fgf9+Bmp7 induced robust differentiation (C).
Epithelial aggregates (Cdh1+, Jag+) are surrounded by Six2+ cells (D). Isolated E11.5 MM cultured in M+H+Fgf9+Bmp7 media and EdU (5-ethynyl-20-
deoxyuridine) for 4–7 hr, washed, and cultured inM+H+Fgf9+Bmp7 for an additional 44 hr. Explants were stainedwith EdU detection kit (E and F), pHH3 (E andG),
and Six2 (E and H) Many Six2+ cells remained EDUbright (E–H, yellow arrows), suggesting that they did not divide again within 48 hr. A few nephron progenitors
Six2+, EDUDimm (cells that divided once after labeling), and pHH3+ cells were able to divide at least once within 2 days of culture. Isolated E11.5 MM was grown
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FGF9/20 Maintain Stemness of Nephron Progenitorsmother was a healthy 25-year-old woman with previous history of termination
of pregnancy at 26 weeks for anhydramnios. In this family, another consan-
guineous couple also experienced two terminations of pregnancy for bilateral
renal agenesis (fetuses 3 and 4 in Figure 5B). At autopsy, fetus 2was eutrophic,
presented the Potter sequence including redundant skin, varus feet, and
pulmonary hypoplasia. Internal examination showed bilateral reno-ureteral
agenesis (Figure 5A). Other organs were normal. X-ray evaluation showed
no anomaly for the gestational age. Neuropathological examination did not
detect any abnormality in brain or eyes.
DNA was extracted from a frozen liver sample of fetus 2. Genotyping was
performed on Illumina Infinium HumanOmni1 beadchip, resulting in the identi-
fication of 26 homozygous genomic regions extending from 35 Mb to 700 Kb
and spanning the genome (data not shown). Whole exome sequencing was
performed using the 50 Mb Agilent SureSelect assay and a SOLiD4 sequencer
(50 base fragment reads). The 1.4 Gb of mappable sequence data were
aligned to the human genome reference sequence (hg19 build) using BWA
aligner (Li and Durbin, 2010). Variants were annotated with in house pipeline
based on the Ensembl database (release 61). Known variants from dbSNP132,
the 1000 Genomes Project and in-house exome data were excluded from the
genetic variants identified in the coding regions or splice sites. Subsequent
filtration of the data was performed in order to select variants located in the
identified homozygous genomic regions, in genes expressed in the early
stages of kidney development (http://www.gudmap.org/) and with a predicted
deleterious effect on the protein (Polyphen, Sift). Mutations identified by
exome sequencing were validated by Sanger sequencing in all available
DNA samples of the family: fetus 2, his parents, a healthy sister, and fetuses
3 and 4. The study was approved by the Comite´ de Protection des Personnes
pour la Recherche Biome´dicale Ile de France 2 and informed consent was
obtained from the parents.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures, one table, and Supple-
mental Experimental Procedures and can be found with this article online at
doi:10.1016/j.devcel.2012.04.018.
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